[direct reporting network Beijing on October 23rd news] (ShuangDi)Recently, the general office of the national development and Reform Commission approved the construction program of gene testing technology demonstration center reported by Dalian, Chongqing and Xiamen Municipal Development and reform commission. ShuangDi Jingtai gene detection platform Approved National Gene Detection Demonstration Center construction tasks.

ShuangDi Jingtai have medical institution; the Liaoning province through clinical inspection center for clinical gene amplification technology laboratory audit; get approved the Dalian Municipal Engineering Laboratory of clinical genetic testing technology; a number of laboratories in the State Planning Commission clinical inspection center organization (national quality assessment in diagnosis and treatment of tumor detection, high-throughput sequencing detection and neonatal deafness gene HPV genotype, EGFR KRAS BRAF PIK3CA cancer drug), a total of seven projects to be carried out by. ShuangDi Jingtai gene detection platform for gene detection approved a national demonstration center, will be based in Dalian, facing the country, efficient service in life science research, public health, health care and other major projects.

In June 2015, the national development and Reform Commission issued the "national development and Reform Commission on the implementation of circular industries major engineering package" (the change in high tech [2015]1303), the gene detection technology demonstration center into one of the six major fields of "new health technology Huimin project", support with core technology, innovation ability and related qualified agencies, take the network layout, the construction of demonstration center, to carry out genetic disorders and birth defects as the key gene screening, genetic testing and other advanced technology to promote the popularization of health Huimin, lead a major innovation achievements industrialization.

ShuangDi gene detection mechanism for men and women of all ages including lung cancer, gastric cancer, liver cancer and 12 high incidence of tumor susceptibility gene screening. Through the comprehensive detection of multiple genes, multilocus analysis, gene mutation or judge whether there is sensitive genotype, disease susceptibility of individuals from the genetic perspective and risk forecast, accurately determine the future ten years, twenty years, thirty years of common diseases and major disease risk.

Let you know early, early prevention and intervention, and provide the scientific system of diet and exercise, health care, health maintenance and management guidelines and treatment plan for you to create personalized human use, truly prolong life and health worries.